Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia

[1]  Liwu Li,et al.  Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-κB Transactivation at the IL-1β Promoter1 , 2005, The Journal of Immunology.

[2]  G. Xiao,et al.  Essential Role of IκB Kinase α in the Constitutive Processing of NF-κB2 p100* , 2005, Journal of Biological Chemistry.

[3]  Malay Mandal,et al.  The BCL2A1 gene as a pre–T cell receptor–induced regulator of thymocyte survival , 2005, The Journal of experimental medicine.

[4]  I. Screpanti,et al.  PKCθ mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia , 2005, Oncogene.

[5]  B. Aronow,et al.  Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .

[6]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[7]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[8]  G. Xiao,et al.  Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.

[9]  A. Sarin,et al.  The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells* , 2004, Journal of Biological Chemistry.

[10]  A. F. Campese,et al.  Pre‐TCR‐triggered ERK signalling‐dependent downregulation of E2A activity in Notch3‐induced T‐cell lymphoma , 2003, EMBO reports.

[11]  D. Green,et al.  RelB/p50 dimers are differentially regulated by TNF-α and lymphotoxin-β receptor activation: critical roles for p100 , 2003 .

[12]  F. Weih,et al.  RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.

[13]  William Arbuthnot Sir Lane,et al.  NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function , 2002, Nature Cell Biology.

[14]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[15]  Gioacchino Natoli,et al.  Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. , 2002, Genes & development.

[16]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[17]  U. Lendahl,et al.  Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[19]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[20]  L. Scorrano,et al.  Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.

[21]  U. Lendahl,et al.  Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.

[22]  W. Greene,et al.  Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions , 2000, Molecular and Cellular Biology.

[23]  H. Fehling,et al.  Crucial role of the pre-T-cell receptor α gene in development of ap but not γδ T cells , 1995, Nature.

[24]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[25]  D. Carrasco,et al.  Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. , 1994, Oncogene.

[26]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[27]  I. Screpanti,et al.  PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia. , 2005, Oncogene.

[28]  G. Xiao,et al.  Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100. , 2005, The Journal of biological chemistry.

[29]  Liwu Li,et al.  Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. , 2005, Journal of Immunology.

[30]  M. Karin,et al.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity. , 2004, Trends in immunology.

[31]  B. Aronow,et al.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.

[32]  D. Green,et al.  RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. , 2003, The Journal of biological chemistry.

[33]  William Arbuthnot Sir Lane,et al.  NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function. , 2002, Nature cell biology.

[34]  D. Green,et al.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.

[35]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[36]  Michael Karin,et al.  NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.

[37]  M. Karin,et al.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.

[38]  H. Fehling,et al.  Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. , 1995, Nature.